22-Apr-2026
TipRanks (Tue, 21-Apr 6:50 AM ET)
Business Wire (Thu, 16-Apr 4:05 PM ET)
The Infrastructure Play Hiding in Plain Sight Across Cardiac Care
Globe Newswire (Thu, 16-Apr 11:00 AM ET)
Business Wire (Thu, 9-Apr 9:00 AM ET)
GE HealthCare to announce first quarter 2026 results on April 29, 2026
Business Wire (Mon, 6-Apr 7:00 AM ET)
GE HealthCare Recommends Shareholders Reject "Mini-Tender" Offer by Potemkin Limited
Business Wire (Tue, 31-Mar 4:10 PM ET)
Business Wire (Thu, 26-Mar 8:30 AM ET)
Business Wire (Wed, 25-Mar 9:00 AM ET)
GE HealthCare's Photonova Spectra photon-counting CT receives FDA clearance
Business Wire (Mon, 23-Mar 9:59 AM ET)
Business Wire (Wed, 18-Mar 4:00 PM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of April 22, 2026, GEHC stock price declined to $71.38 with 3,284,742 million shares trading.
GEHC has a beta of 1.50, meaning it tends to be more sensitive to market movements. GEHC has a correlation of 0.47 to the broad based SPY ETF.
GEHC has a market cap of $32.57 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $6 billion in Revenue and $1.44 earnings per share. This beat revenue expectation by $99 million and exceeded earnings estimates by $.03.
In the last 3 years, GEHC traded as high as $94.80 and as low as $57.65.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, VOO, QQQ, VO, IVV.
GEHC has underperformed the market in the last year with a price return of +18.3% while the SPY ETF gained +39.8%. GEHC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -11.9% and +2.4%, respectively, while the SPY returned +4.0% and +7.9%, respectively.
GEHC support price is $70.81 and resistance is $73.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.
